Amgen’s Plan To Go Big In Obesity

Competing in the obesity market will require significant investment, which Amgen is preparing for, CEO Robert Bradway told investors during the Morgan Stanley Healthcare conference.

More from Alimentary/Metabolic

More from Therapy Areas